FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080562 [Registered on: 14/02/2025] Trial Registered Prospectively
Last Modified On: 13/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   Individualized homoeopathic medicine in gout using kents method of evaluation of symptoms 
Scientific Title of Study   Role of individualized homoeopathic medicine in management of gout according to kents method of evaluation of symptoms 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shruti Dixit 
Designation  Post Graduate trainee 
Affiliation  State National Homoeopathic Medical College and Hospital Viraj Khand 1 Gomti Nagar Lucknow 
Address  Department of Organon of Medicine and Homoeopathic Philosophy State National Homoeopathic Medical College and Hospital Viraj Khand 1 Gomti Nagar Lucknow

Lucknow
UTTAR PRADESH
226010
India 
Phone  8171104641  
Fax    
Email  shrutidixit126@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Archna Kumari  
Designation  Reader 
Affiliation  State National Homoeopathic Medical College and Hospital Viraj Khand 1 Gomti Nagar Lucknow 
Address  Department of Organon of Medicine and Homoeopathic Philosophy State National Homoeopathic Medical College and Hospital Viraj Khand 1 Gomti Nagar Lucknow

Lucknow
UTTAR PRADESH
226010
India 
Phone  9450522295  
Fax    
Email  archna505@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shruti Dixit 
Designation  Post Graduate Trainee 
Affiliation  State National Homoeopathic Medical College and Hospital Viraj Khand 1 Gomti Nagar Lucknow 
Address  Department of Organon of Medicine and Homoeopathic Philosophy State National Homoeopathic Medical College and Hospital Viraj Khand 1 Gomti Nagar Lucknow

Lucknow
UTTAR PRADESH
226010
India 
Phone  8171104641  
Fax    
Email  shrutidixit126@gmail.com  
 
Source of Monetary or Material Support  
Out Patient Department of State National Homoeopathic Medical College and Hospital Viraj Khand 1 Gomti Nagar Lucknow 
 
Primary Sponsor  
Name  Dr Shruti Dixit 
Address  Department of Organon of Medicine and Homoeopathic Philosophy State National Homoeopathic Medical College and Hospital Viraj Khand 1 Gomti Nagar Lucknow 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shruti Dixit  State National Homoeopathic Medical College and Hospital Lucknow  OPD-8 Department of Organon of Medicine and Homoeopathic philosophy Sate National Homoeopathic Medical College and Hospital Viraj Khand 1 Gomti Nagar Lucknow
Lucknow
UTTAR PRADESH 
8171104641

shrutidixit126@gamil.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee of State National Homoeopathic Medical College and Hospital Lucknow  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M109||Gout, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualized Homoeopathic Medicine according to Kents method of evaluation of symptoms  Patients qualifying to inclusion criteria will be included in the study. Proper case taking of all enrolled patients will be done in standardized case taking proforma which is being used in State National Homoeopathic medical college and hospital. Homoeopathic medicines will be prescribed to all patients after analysis and evaluation of symptoms and proper repertorization using Repertory of the Homoeopathic Materia Medica by James Tyler Kent. Indicated homoeopathic remedy will be administered as per the requirement to the case or condition in appropriate potency (30 CH, 200 CH,1M) and appropriate doses. Medicines will be given oral route. Each case will be followed up at regular interval preferably at a period of 15 days or as per requirement. Patient will be studied for 6 months after enrolment in study. Outcome assessment of the patients will be carried out after 6 months of homoeopathic medication based on Gout Impact scale scoring between 0 to 100. 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  .Patients fulfilling the diagnostic criteria of Gout.
.Serum urate levels equal to or more than 6.8mg per dl.(According to WHO)
.Individuals with a family history of gout.
.Patients aged 18 to 60 years.
 
 
ExclusionCriteria 
Details  .Patients with any severe systemic illness.
.Pregnant females, lactating mothers, and women who are planning for pregnancy.
.Patients not willing to participate in the study.

 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To evaluate the effect of individualized homoeopathic medicine selected using Repertory of Homoeopathic Materia Medica by James Tyler Kent using Gout Impact Scale before and after the treatment.  30 days 
 
Secondary Outcome  
Outcome  TimePoints 
.At the end of the study it is expected that Homoeopathic medicine selected on the basis of individualization according to Kents approach will prove effective in the management of Gout.
.The study will determine whether the Quality of Life of the patients suffering from Gout can be improved by using Individualized Homoeopathic Medicine. 
3 months 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   25/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Gout is a type of inflammatory arthritic disorder characterized by sudden, severe joint pain, swelling and limited joint mobility caused by an excess of uric acid in the blood, leading to the formation of sharp, needle-like urate crystals in the joints. Gout commonly affects the joint at the base of the big toe (podagra), but it can also occur in other joints such as ankles, knees, wrists, and elbows. The condition is one of the most common types of arthritis and is more prevalent in men than women. The risk factors of gout includes age, sex, obesity, hypertension, diabetes, kidney disease, diet, genetic factors, cardiovascular diseases.

At the end of study, it is expected that the individualized homoeopathic medicine selected using Repertory of Homoeopathic Materia Medica by James Kent have effective role in the management of patients who are suffering with Gout. It is expected that the patient improves symptomatically which is evident through the valid scale (Gout Impact Scale). This study will further emphasize the importance of mind symptoms in treating patients suffering from chronic systemic illnesses like Gout.
 
Close